Patent · US Active

Therapeutic interferon alpha 1 proteins

US11440943B2 · kind B2 · utility

0Cited by

15References

11Claims

0Family size

Assignee

Orionis Biosciences, Inc · US

Inventors

Nikolai KLEY · Waltham, US
Erik Depla · Laarne, BE
Lennart ZABEAU · Evergem, BE
Jan Tavernier · Balegem, BE

Key dates

Filing date	Mar 27, 2020
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Apr 11, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates, in part, to chimeric proteins or chimeric protein complexes, such as Fc-based chimeric protein complexes, comprising interferon alpha 1, or a variant thereof, and their use as therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.